{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:24:19Z","timestamp":1775438659728,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Extracranial metastasis (EM) from glioblastoma (GB), IDH-wildtype (WHO CNS 2021 grade 4) is rare and often under-recognized, yet it has immediate implications for staging and management. We report a case series integrating advanced neuroimaging, whole-body imaging, and pathology\/biomarkers to characterize imaging\u2013pathology correlates of EM and highlight practical clinical triggers that should prompt systemic evaluation. Case presentation: We report three patients with adult-type, IDH-wildtype GB who developed EM confirmed by cytology\/histology and\/or concordant multimodality imaging. Brain MRI (1.5T\/3T) demonstrated aggressive primary tumors with qualitative elevation of DSC-perfusion and frequent tumor\u2013surface contact (dural, ependymal\/leptomeningeal contact). Intratumoral susceptibility signal reached grade 3 where assessed. All patients underwent surgical resection followed by temozolomide-based chemoradiation; two received fotemustine and bevacizumab, and one underwent re-irradiation. EM presented with clinical triggers including severe axial\/back pain, palpable cervical masses, and\/or cytopenias. Initial EM sites were bone marrow\/vertebrae (n = 1) and cervical lymph nodes (n = 2); staging revealed additional osseous disease in both nodal cases and a small pulmonary nodule in one. Nodal and osseous lesions were FDG-avid on 18F-FDG PET\/CT. OLIG2-positive cytology confirmed cervical nodal metastases, and bone marrow aspiration with GFAP\/OLIG2 positivity confirmed medullary infiltration. All tumors shared a molecular profile of TERT-promoter mutation, ATRX wild-type, TP53 mutation, and MGMT-promoter methylation. Despite attempts at second- and third-line therapies, disease progression was rapid, and all patients succumbed within 8\u201316 months of diagnosis. Discussion: This series underscores that EM can occur despite MGMT-promoter methylation and supports the concept of heterogeneous metastatic phenotypes in GB. Our cases reinforce that new axial\/back pain or hematologic abnormalities may signal osseous or marrow involvement, and necrotic cervical lymphadenopathy in GB patients warrants dedicated imaging and tissue confirmation with glial markers. Integrating brain MRI features (high perfusion, surface contact, susceptibility burden) with FDG-PET\/CT and targeted cytology\/pathology can expedite diagnosis and inform multidisciplinary care. Conclusions: EM can arise despite MGMT-promoter methylation in IDH-wildtype GBM. Imaging red flags (high perfusion, surface contact, necrotic\/FDG-avid cervical nodes) and clinical cues (axial pain, cytopenias, neck masses) should prompt early systemic staging (CT\/PET-CT) and targeted tissue confirmation to advance management.<\/jats:p>","DOI":"10.3390\/diagnostics16071094","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:19:32Z","timestamp":1775434772000},"page":"1094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracranial Metastases in Glioblastoma, IDH-Wildtype: A Case Series"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-2875","authenticated-orcid":false,"given":"Val\u00e8ria","family":"Richart","sequence":"first","affiliation":[{"name":"Department of Radiology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Garc\u00eda de Herreros","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Andr\u00e9s","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Pineda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-7453","authenticated-orcid":false,"given":"Iban","family":"Aldecoa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clinic de Barcelona, University of Barcelona, and Neurological Tissue Bank of the Biobank, FCRB\/IDIBAPS, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-747X","authenticated-orcid":false,"given":"Estela","family":"Pineda","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-7281","authenticated-orcid":false,"given":"Izaskun","family":"Valduvieco","sequence":"additional","affiliation":[{"name":"Radiotherapy Oncology Service, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7589-6575","authenticated-orcid":false,"given":"Jos\u00e9 Juan","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-0451","authenticated-orcid":false,"given":"Laura","family":"Oleaga","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Gonz\u00e1lez-Ortiz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Grochans, S., Cybulska, A.M., Simi\u0144ska, D., Korbecki, J., Kojder, K., Chlubek, D., and Baranowska-Bosiacka, I. (2022). Epidemiology of Glioblastoma Multiforme\u2013Literature Review. Cancers, 14.","DOI":"10.3390\/cancers14102412"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3174\/ajnr.A7462","article-title":"The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know","volume":"43","author":"Osborn","year":"2022","journal-title":"Am. J. Neuroradiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/030089160809400109","article-title":"Extra central nervous system metastases from cerebral glioblastoma multiforme in elderly patients. Clinico-pathological remarks on our series of seven cases and critical review of the literature","volume":"94","author":"Piccirilli","year":"2008","journal-title":"Tumori J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-011-0575-8","article-title":"The natural history of extracranial metastasis from glioblastoma multiforme","volume":"105","author":"Lun","year":"2011","journal-title":"J. Neurooncol."},{"key":"ref_7","first-page":"8","article-title":"Spongioblastoma Multiforme of the Brain","volume":"87","author":"Davis","year":"1928","journal-title":"Ann. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rossi, J., Giaccherini, L., Cavallieri, F., Napoli, M., Moratti, C., Froio, E., Serra, S., Fraternali, A., Ghadirpour, R., and Cozzi, S. (2020). Extracranial metastases in secondary glioblastoma multiforme: A case report. BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01959-y"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/1806-9282.65.3.424","article-title":"Metastasis from glioblastoma multiforme: A meta-analysis","volume":"65","author":"Maldaun","year":"2019","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000492111","article-title":"Extracranial Metastases of a Cerebral Glioblastoma: A Case Report and Review of the Literature","volume":"11","author":"Rosen","year":"2018","journal-title":"Case Rep. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semcancer.2019.10.010","article-title":"Brain malignancies: Glioblastoma and brain metastases","volume":"60","author":"Lah","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_12","first-page":"e1905","article-title":"Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited","volume":"6","author":"Kurdi","year":"2023","journal-title":"Cancer Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pietschmann, S., Von Bueren, A.O., Kerber, M.J., Baumert, B.G., Kortmann, R.D., and M\u00fcller, K. (2015). An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma\/ gliosarcoma patients with metastases outside of the central nervous system. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121592"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11060-009-0044-9","article-title":"Multiple extracranial metastases from secondary glioblastoma multiforme: A case report and review of the literature","volume":"97","author":"Zhen","year":"2010","journal-title":"J. Neuro-Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e38794","DOI":"10.1097\/MD.0000000000038794","article-title":"A case series of osseous metastases in patients with glioblastoma","volume":"103","author":"Webb","year":"2024","journal-title":"Medicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1590\/1806-9282.65.3.460","article-title":"Systemic dissemination of glioblastoma: Literature review","volume":"65","author":"Feher","year":"2019","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/neuonc\/noz129","article-title":"Molecular profiling of long-term IDH-wildtype glioblastoma survivors","volume":"21","author":"Burgenske","year":"2019","journal-title":"Neuro Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/PAS.0000000000001762","article-title":"TP53 Mutation and Extraneural Metastasis of Glioblastoma Insights from an Institutional Experience and Comprehensive Literature Review","volume":"45","author":"Zhang","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_19","first-page":"325","article-title":"A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center","volume":"8","author":"Noch","year":"2021","journal-title":"Neurooncol. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.2013.48.7546","article-title":"Glioblastoma Multiforme Metastasis Outside the CNS: Three Case Reports and Possible Mechanisms of Escape","volume":"32","author":"Hamilton","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3171\/2013.3.JNS122226","article-title":"Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms","volume":"119","author":"Nduom","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-004-3346-y","article-title":"Bone marrow metastases from glioblastoma multiforme\u2014A case report and review of the literature","volume":"72","author":"Rajagopalan","year":"2005","journal-title":"J. Neurooncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/A:1005909127196","article-title":"Bone marrow metastasis in astrocytic gliomata","volume":"37","author":"Hsu","year":"1998","journal-title":"J. Neurooncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.26599\/BSA.2021.9050023","article-title":"Evaluation of the malignant potential of gliomas using diffusion-weighted and gadolinium-enhanced magnetic resonance imaging","volume":"7","author":"Takaya","year":"2021","journal-title":"Brain Sci. Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3174\/ajnr.A1593","article-title":"Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: Comparison with MR perfusion imaging","volume":"30","author":"Park","year":"2009","journal-title":"Am. J. Neuroradiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.acra.2017.10.001","article-title":"Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis","volume":"25","author":"Liang","year":"2018","journal-title":"Acad. Radiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3174\/ajnr.A8521","article-title":"Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single Center Case Series","volume":"46","author":"Eldaya","year":"2025","journal-title":"Am. J. Neuroradiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Begagi\u0107, E., Pugonja, R., Be\u010duli\u0107, H., \u010celikovi\u0107, A., Tandir Lihi\u0107, L., Kadi\u0107 Vukas, S., \u010cejvan, L., Skomorac, R., Selimovi\u0107, E., and Jaganjac, B. (2023). Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings. Brain Sci., 13.","DOI":"10.3390\/brainsci13111602"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-022-04025-4","article-title":"Bone metastasis from glioblastoma: A systematic review","volume":"159","author":"Strong","year":"2022","journal-title":"J. Neuro-Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/7\/1094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:31:40Z","timestamp":1775435500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/7\/1094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diagnostics16071094"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16071094","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]}}}